Dystrophin Loss in Engineered Heart Tissues Recapitulates Clinically Relevant Aspects of Dystrophic Cardiomyopathy
Journal of Biomechanical Engineering · 2026
DOI: 10.1115/1.4070408 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomechanical Engineering, 2026. Verfasst von Alex J Goldstein und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Lab Medicine and Pathology, University of Washington, Seattle, WA 98195. Hauptthemen laut MEDLINE: Dystrophin, Tissue Engineering, Cardiomyopathy, Dilated, Myocardium. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIAMS NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Heart failure is the leading cause of death in patients with Duchenne muscular dystrophy (DMD), but the mechanisms underlying the associated dilated cardiomyopathy (DCM) are not fully understood. To address this gap, we generated engineered heart tissues (EHTs) using CRISPR-edited human induced pluripotent stem cell-derived cardiomyocytes that lack dystrophin. These dystrophic EHTs reproduced aspects of systolic and diastolic dysfunction seen in DMD-related DCM as they showed impaired contractile function and slower kinetics. Increased beat rate variability was also observed in dystrophic EHTs. Accompanying these facets of the DMD pathology were attenuated Ca2+ transients and delayed kinetics. Lastly, histological analysis of EHTs revealed that dystrophin-null cardiomyocytes had reduced size and shorter sarcomere lengths when compared to isogenic controls. Together, these findings demonstrate that EHTs provide a physiologically relevant human model of DMD-associated DCM and may serve as a valuable platform for mechanistic studies and therapeutic testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Lab Medicine and Pathology, University of Washington, Seattle, WA 98195.
- Department of Mechanical Engineering, University of Washington, Seattle, WA 98195.
- Department of Rehabilitation Medicine, University of Washington, Seattle, WA 98195.
Förderung
- NHLBI NIH HHS
- NIAMS NIH HHS
- NIDDK NIH HHS
- National Heart, Lung, and Blood Institute
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Goldstein, A. J., Leahy, T. P., Mack, D. L., & Sniadecki, N. J. (2026). Dystrophin Loss in Engineered Heart Tissues Recapitulates Clinically Relevant Aspects of Dystrophic Cardiomyopathy. Journal of Biomechanical Engineering. https://doi.org/10.1115/1.4070408
Vancouver
Goldstein AJ, Leahy TP, Mack DL, Sniadecki NJ. Dystrophin Loss in Engineered Heart Tissues Recapitulates Clinically Relevant Aspects of Dystrophic Cardiomyopathy. Journal of Biomechanical Engineering. 2026. doi:10.1115/1.4070408
BibTeX
@article{Goldstein2026,
author = {Goldstein, Alex J and Leahy, Thomas P and Mack, David L and Sniadecki, Nathan J},
title = {Dystrophin Loss in Engineered Heart Tissues Recapitulates Clinically Relevant Aspects of Dystrophic Cardiomyopathy},
journal = {Journal of Biomechanical Engineering},
year = {2026},
doi = {10.1115/1.4070408}
}
EUVIMED